New treatment option for Dementia
Official title 5-Cog 2.0: A Pragmatic Clinical Trial
ClinicalTrials.gov ID: NCT05515224
What this study is testing
- What it's testing
- Cognitive impairment related to dementia is frequently under-diagnosed in primary care settings. This problem is more prevalent in health disparities populations.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- 65 years and older
- Presence of cognitive concerns
- English or Spanish speaking.
- Able to see and hear well enough to complete assessments.
You likely can't join if
- Prior diagnosis of dementia (documented in the electronic medical record or reported by physicians).
- Permanent nursing facility residents.
The study team makes the final eligibility decision.
Where it's taking place
- Bloomington, Indiana, United States
- The Bronx, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bloomington, Indiana, United States; The Bronx, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.